Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Elomaa

Showing results (31-40 of 143) with videos related to

Pageof 15
Sort By:
International Journal of Clinical Pharmacology, Therapy, and Toxicology|December 1, 1989
Pharmacokinetics of disodium clodronate after daily intravenous infusions during five consecutive daysH Hanhijärvi, I Elomaa, M Karlsson, et al.
Oncology|August 31, 2001
A phase I study of raltitrexed (Tomudex) combined with carmofur in metastatic colorectal cancerP Osterlund, I Elomaa, P Virkkunen, et al.
British Journal of Haematology|August 1, 1994
Subgroup and cost-benefit analysis of the Finnish multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia GroupM Laakso, R Lahtinen, P Virkkunen, et al.
Journal of Internal Medicine|January 1, 1989
Experiences of clodronate treatment of multifocal eosinophilic granuloma of boneI Elomaa, C Blomqvist, L Porkka, et al.
Archives of Pathology & Laboratory Medicine|September 1, 1984
Hypercalcemia and elevated serum parathyroid hormone level in association with rhabdomyosarcomaI Elomaa, V P Lehto, R K Selander
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trialT Saarto, C Blomqvist, P Virkkunen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Weekly low-dose doxorubicin with or without high-dose medroxyprogesterone acetate as secondary treatment in metastatic breast cancer--a randomized trialI Elomaa, C Blomqvist, P Rissanen, et al.
Bone|January 1, 1987
Cytogenetic investigations of patients on clodronate therapy for Paget's disease of boneG H Borgström, I Elomaa, C Blomqvist, et al.
Scandinavian Journal of Gastroenterology|September 1, 1987
Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulphonamidesU Turunen, I Elomaa, V J Anttila, et al.
European Urology|January 1, 1991
Hormone-resistant metastatic prostate cancer. Comparisons between estramustine phosphate and low-dose epirubicin treatmentsI Elomaa, P Kellokumpu-Lehtinen, S Rannikko, et al.
Pageof 15

Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
International Journal of Clinical Pharmacology, Therapy, and Toxicology|December 1, 1989
Pharmacokinetics of disodium clodronate after daily intravenous infusions during five consecutive daysH Hanhijärvi, I Elomaa, M Karlsson, et al.
Oncology|August 31, 2001
A phase I study of raltitrexed (Tomudex) combined with carmofur in metastatic colorectal cancerP Osterlund, I Elomaa, P Virkkunen, et al.
British Journal of Haematology|August 1, 1994
Subgroup and cost-benefit analysis of the Finnish multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia GroupM Laakso, R Lahtinen, P Virkkunen, et al.
Journal of Internal Medicine|January 1, 1989
Experiences of clodronate treatment of multifocal eosinophilic granuloma of boneI Elomaa, C Blomqvist, L Porkka, et al.
Archives of Pathology & Laboratory Medicine|September 1, 1984
Hypercalcemia and elevated serum parathyroid hormone level in association with rhabdomyosarcomaI Elomaa, V P Lehto, R K Selander
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trialT Saarto, C Blomqvist, P Virkkunen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Weekly low-dose doxorubicin with or without high-dose medroxyprogesterone acetate as secondary treatment in metastatic breast cancer--a randomized trialI Elomaa, C Blomqvist, P Rissanen, et al.
Bone|January 1, 1987
Cytogenetic investigations of patients on clodronate therapy for Paget's disease of boneG H Borgström, I Elomaa, C Blomqvist, et al.
Scandinavian Journal of Gastroenterology|September 1, 1987
Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulphonamidesU Turunen, I Elomaa, V J Anttila, et al.
European Urology|January 1, 1991
Hormone-resistant metastatic prostate cancer. Comparisons between estramustine phosphate and low-dose epirubicin treatmentsI Elomaa, P Kellokumpu-Lehtinen, S Rannikko, et al.
Pageof 15